Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020.

ABSTRACT: Pulmonary endarterectomy is the treatment of choice for patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) as it is potentially curative. In expert centers that conduct > 50 pulmonary endarterectomy procedures per year, peri- and post-surgical mortality rates are very low and long-term outcomes are excellent, with three-year post-operative survival of > 80%. Therapeutic decisions in CTEPH are based largely on the location of the arterial obstruction, with pulmonary endarterectomy for obstructions in main, lobar, and segmental vessels, and balloon pulmonary angioplasty and medical therapy for small-vessel disease. Medical therapy is also an option for patients with persistent/recurrent pulmonary hypertension after pulmonary endarterectomy or balloon pulmonary angio

SUBMITTER: Madani MM 

PROVIDER: S-EPMC8150486 | biostudies-literature | 2021 Apr-Jun

REPOSITORIES: biostudies-literature